Asked by: Al Pinkerton (Liberal Democrat - Surrey Heath)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of diagnosis and ongoing care for people with Crohn’s disease and Colitis in Surrey Heath constituency.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Integrated care boards (ICBs) are responsible for ensuring that appropriate treatment and support is available for people diagnosed with inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, in their areas. In Surrey Heath, this responsibility sits with either the NHS Frimley ICB or the NHS Surrey Heartlands ICB, with national improvement programmes such as Getting It Right First Time (GIRFT) and NHS RightCare driving change. Together, these programmes help deliver consistent, high-quality diagnostic processes and ongoing care and support across the National Health Service in England.
The GIRFT national report on gastroenterology recommends rapid access to specialist review within four weeks, personalised care plans, increased endoscopy capacity, the standardised use of diagnostic tests such as endoscopy and imaging, and early involvement of multidisciplinary teams, including IBD specialist nurses, gastroenterologists, surgeons, dietitians, and mental health professionals.
In November 2025, GIRFT published a new handbook, ‘Optimising care for patients with Inflammatory Bowel Disease’ in addition to an updated IBD pathway. This handbook provides practical advice, key actions, and examples of innovative practices to improve the care of NHS patients with Crohn's disease and ulcerative colitis.
‘Hannah’s story’, published by NHS England as part of its RightCare scenario series, is a fictional case study designed to show the difference between a suboptimal and an optimal care pathway for someone living with Crohn’s disease. This scenario underlines the importance of integrated services, proactive treatment planning, and consistent adherence to IBD Standards to reduce variation and improve outcomes for patients across England.
Gastroenterology is a high-volume specialty identified as a top priority for reform in the Elective Reform Plan due to its waiting list challenges. Specific action in gastroenterology includes developing an integrated pathway across primary, community, and secondary care for common gastroenterology conditions. We will also drive rapid adoption of remote monitoring in appropriate gastroenterology pathways.
We are also introducing an ‘online hospital’ through NHS Online. This will give people on certain pathways the choice of getting the specialist care they need from their home, providing additional appointments to cut waiting times. IBD is amongst nine initial conditions for online referrals from 2027.
Asked by: Al Pinkerton (Liberal Democrat - Surrey Heath)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the support available to people living with Crohn’s disease and Colitis in Surrey Heath constituency.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Integrated care boards (ICBs) are responsible for ensuring that appropriate treatment and support is available for people diagnosed with inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, in their areas. In Surrey Heath, this responsibility sits with either the NHS Frimley ICB or the NHS Surrey Heartlands ICB, with national improvement programmes such as Getting It Right First Time (GIRFT) and NHS RightCare driving change. Together, these programmes help deliver consistent, high-quality diagnostic processes and ongoing care and support across the National Health Service in England.
The GIRFT national report on gastroenterology recommends rapid access to specialist review within four weeks, personalised care plans, increased endoscopy capacity, the standardised use of diagnostic tests such as endoscopy and imaging, and early involvement of multidisciplinary teams, including IBD specialist nurses, gastroenterologists, surgeons, dietitians, and mental health professionals.
In November 2025, GIRFT published a new handbook, ‘Optimising care for patients with Inflammatory Bowel Disease’ in addition to an updated IBD pathway. This handbook provides practical advice, key actions, and examples of innovative practices to improve the care of NHS patients with Crohn's disease and ulcerative colitis.
‘Hannah’s story’, published by NHS England as part of its RightCare scenario series, is a fictional case study designed to show the difference between a suboptimal and an optimal care pathway for someone living with Crohn’s disease. This scenario underlines the importance of integrated services, proactive treatment planning, and consistent adherence to IBD Standards to reduce variation and improve outcomes for patients across England.
Gastroenterology is a high-volume specialty identified as a top priority for reform in the Elective Reform Plan due to its waiting list challenges. Specific action in gastroenterology includes developing an integrated pathway across primary, community, and secondary care for common gastroenterology conditions. We will also drive rapid adoption of remote monitoring in appropriate gastroenterology pathways.
We are also introducing an ‘online hospital’ through NHS Online. This will give people on certain pathways the choice of getting the specialist care they need from their home, providing additional appointments to cut waiting times. IBD is amongst nine initial conditions for online referrals from 2027.
Asked by: Kevin Hollinrake (Conservative - Thirsk and Malton)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 19 November 2025 to Question 84923 on Public Houses: Electronic Cigarettes, whether his Department has assessed the potential impact of a ban on vaping in pubs on their (a) financial viability and (b) profitability.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Tobacco and Vapes Bill gives the Government powers to make most public places and workplaces that are smoke-free also vape-free.
We plan to consult on making most indoor settings, that are subject to existing smoke-free legislation, vape-free. This would include inside pubs and other hospitality venues. A number of places have already done this voluntarily.
These measures will be subject to a full consultation, and we will be guided by public health advice. All future regulations will be accompanied by an impact assessment that will consider the economic effects of the proposed measures and will be published as part of the consultation process.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to improve quality of life for people being diagnosed, treated for or living with cancer under the National Cancer Plan.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Cancer Plan for England will have patients at its heart and will cover the entirety of the cancer pathway, from referral and diagnosis to treatment and ongoing care, as well as prevention, and research and innovation. It will seek to improve every aspect of cancer care in England to better the experience and outcomes for people with cancer.
The plan will aim to improve how, in England, the physical and psychosocial needs of people with cancer can be met, with a focus on personalised care to improve quality of life. It will address how the experience of care can be improved for those diagnosed, treated, and living with and beyond cancer in England.
Asked by: James McMurdock (Independent - South Basildon and East Thurrock)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to address regional disparities in whooping cough vaccination uptake among pregnant women.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The latest published data for September 2025 shows that prenatal pertussis vaccination coverage has improved in all seven NHS England regions when compared to September 2024.
The UK Health Security Agency (UKHSA) report shows monthly prenatal pertussis vaccination coverage followed an increasing trend since April 2024. The report is available at the following link:
To support continued improvements, NHS England has developed and implemented a vaccination in pregnancy improvement plan. Actions delivered to date include:
- system level oversight and leadership of programme commissioning and delivery, to strengthen the offer process and tackle factors contributing to low vaccine uptake;
- ensuring commissioned providers are aware of their responsibilities within the vaccination in pregnancy programmes and are working to strengthen the vaccination offer and ensure consistency in delivery approach;
- commissioning community pharmacy providers in areas of low uptake and high deprivation to deliver National Health Service pertussis vaccinations to pregnant women opportunistically or on request;
- revised governance arrangements for vaccination in pregnancy programmes, with regional and national colleagues meeting regularly to share learning and good practice from local systems; and
- improved vaccination recording and accurate data collection to monitor programme effectiveness, allowing regional teams and their partner integrated care boards to access timely NHS operational data. This informs targeted action to increase uptake and reduce inequalities.
Asked by: James McMurdock (Independent - South Basildon and East Thurrock)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate he has made of the proportion of pregnant women who are not offered the whooping cough vaccine by 20 weeks’ gestation; and what steps are being taken to improve timely access.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
All pregnant women in England should be offered the pertussis vaccination in every pregnancy, around the time of the mid-pregnancy scan, usually 20 weeks, and ideally before 32 weeks.
Recent data shows maternal pertussis vaccination coverage from July to September 2025 was 71.9%, which was 7.5% higher than the equivalent period in 2025. The data is available at the following link:
NHS England has implemented a range of measures to ensure timely access to the pertussis vaccination programme, including NHS England and the UK Health Security Agency having developed a joint maternal vaccines toolkit and campaign to promote timely uptake of respiratory syncytial virus (RSV), whooping cough, and flu vaccines during pregnancy, highlighting the protection provided to newborns.
NHS England has commissioned community pharmacies in the North West, Midlands, London, and the East of England to deliver pertussis and RSV vaccines, increasing convenience and capacity, particularly in areas of high deprivation and low uptake.
A maternal vaccination postcard has been translated into seven additional languages and distributed to 200 practices with lower uptake. Tailored communications are shared through community and faith-based channels, including radio, podcasts, and local publications.
NHS England regularly shares vaccination information with pregnancy and parenting organisations such as Tommy’s and the NCT, as well as community and faith groups, for use on their websites, newsletters, and social media.
Asked by: Richard Tice (Reform UK - Boston and Skegness)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the annual cost to the NHS is of providing healthcare to illegal migrants.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department of Health and Social Care and NHS England do not hold the information requested. The overall management of asylum seekers is a matter for the Home Office.
Asked by: Julian Lewis (Conservative - New Forest East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the oral contribution of the Parliamentary Under-Secretary of State for Health and Social Care in the Westminster Hall debate on Parkinson's disease on 17 November 2025, col. 230WH, what steps he will take to encourage medical researchers to propose more projects for National Institute for Health and Care Research funding to help cure that disease.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department invests over £1.6 billion each year on research through its research delivery arm, the National Institute for Health and Care Research (NIHR). In the 2024/25 financial year, the NIHR committed £6 million to Parkinson’s disease research through its research programmes and capacity building schemes.
As well as funding research itself, the NIHR invests significantly in research expertise and capacity, specialist facilities, support services, and collaborations to support and deliver research in England. Collectively this forms NIHR infrastructure. NIHR infrastructure enables the country’s leading experts to develop and deliver high-quality translational, clinical, and applied research into Parkinson’s disease.
In order to inform priorities and guide future research commissioning by funders of Parkinson’s research, the NIHR Dementia and Neurodegeneration Policy Research Unit at Exeter has undertaken a mapping exercise of the current evidence landscape.
The NIHR continues to welcome funding applications for research into any aspect of human health and care, including Parkinson’s disease. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.
Welcoming applications on Parkinson's disease to all NIHR programmes enables maximum flexibility both in terms of amount of research funding a particular area can be awarded, and the type of research which can be funded.
Asked by: Jayne Kirkham (Labour (Co-op) - Truro and Falmouth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps are being taken to encourage the use of a surgical robot in Cornwall, in the context of it being the only region in England and Wales without one.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
Our 10-Year Health Plan commits to expanding surgical robot adoption over the next decade. We recognise the importance of ensuring equitable access and we will establish national registries for robotic surgery data from 2029 and develop telesurgery networks to support geographical equity of access to robotic assisted surgery.
Decisions on the procurement of robotic‑assisted surgery are made locally by NHS trusts and integrated care boards, in line with local need and national guidance. The Royal Cornwall Hospitals NHS Trust (RCHT) has a robotic surgery programme as a commitment in their refreshed 10-year strategy, which was approved at the RCHT Board on 8 January 2026.
Asked by: Jas Athwal (Labour - Ilford South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of Matha's Rule on enhancing patient care and saving lives for those with learning disabilities.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
Martha’s Rule is being implemented in all acute hospitals in England. Early indications suggest a positive impact on patient care across patient groups, including people with learning disabilities, through improved recognition of physiological deterioration, strengthened patient and family voice, and earlier clinical review.
Data published by NHS England shows that from September 2024 to November 2025, 9,135 Martha’s Rule calls were made, with the highest proportion of calls, or 72%, made via the family escalation process. 3,186 Martha’s Rule escalation calls, or 36%, related to acute deterioration and of those, 412 calls resulted in potentially life-saving transfers of care.